We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Year-over-year BioSpace data shows there were fewer job postings live on the website in the fourth quarter of 2024, and the ...

Biohaven boasts a robust pipeline with late-stage molecules, but a Hold rating reflects its high market cap and uncertain ...

HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, ...

With another JP Morgan in the rearview mirror ... Andrew Obershain, CEO of bluebird bio, said as much on stage. A year before the FDA approved his company’s gene therapy for sickle cell ...

Global markets have been experiencing fluctuations, with U.S. stocks ending the week lower amid tariff uncertainties and mixed economic indicators such as a cooling labor market and expanding ...

Pioneering license agreement with BrainTransporter signed with BMS worth up to USD 1.35 billion plus royalties Events during the fourth quarter 2024 The Australian Medicines Agency (TGA) decided not ...

In the early 20th century – a time when men held most positions of authority – Greene was a celebrated book agent, a curator ...